Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katrin Dreißiger"'
Publikováno v:
Platelets, Vol 31, Iss 5, Pp 680-684 (2020)
MgSO4 is effective in preventing spontaneous in vitro platelet agglutination in anticoagulant-induced pseudothrombocytopenia (PTCP). In order to learn more about its potential as an in vitro anticoagulant, platelets from MgSO4-anticoagulated blood we
Externí odkaz:
https://doaj.org/article/d1aed488ab234f2d9835acb0be42d162
Autor:
Gabriele Siegert, Maximilian Bachem, Michael Steiner, Alexa Bierlich, Peter Kohlschein, Steffen Mannuß, Peter Schuff-Werner, Hans-Jürgen Gross, Sebastian Fenger, Katrin Dreissiger
Publikováno v:
British Journal of Haematology
Pseudothrombocytopenia remains a challenge in the haematological laboratory. The pre-analytical problem that platelets tend to easily aggregate in vitro, giving rise to lower platelet counts, has been known since ethylenediamine-tetra acetic acid EDT
Publikováno v:
American journal of clinical pathology. 145(6)
Objectives: There are conflicting reports on the reliable measurement of platelet count and mean platelet volume (MPV) using EDTA or citrate. The anticoagulant properties of magnesium sulfate (MgSO4) are known from the literature. The aim of this stu
Autor:
Peter Schuff-Werner, Christine Burstein, Aliaksandra Maroz, Joachim Linssen, Katrin Dreißiger, Peter Kohlschein
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
The distinction between reactive and neoplastic leukocytes, especially atypical lymphocytes suspected to be reactive or neoplastic, is a particular challenge in automated hematological cell differentiation. The aim of the study was to evaluate the pe
Publikováno v:
The Heart Surgery Forum. 18:090
Thrombocytopenia might be an exclusion criterion for invasive radiofrequency catheter ablation; therefore it is necessary to differentiate between pseudo-thrombocytopenia and a low platelet count due to other etiologies.A 69-year-old female presented
Publikováno v:
BMC Complementary and Alternative Medicine
Background A major challenge in pancreatic cancer treatment is the resistance of human pancreatic cancer cells to apoptosis. Soy isoflavones and calpain inhibition have been suggested to exert inhibitory effects on cancer development and progression.